INVO Bioscience Price Prediction

INVODelisted Stock  USD 0.84  0.03  3.45%   
As of today, the value of RSI of INVO Bioscience's share price is approaching 45. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling INVO Bioscience, making its price go up or down.

Oversold Vs Overbought

45

 
Oversold
 
Overbought
The successful prediction of INVO Bioscience's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with INVO Bioscience, which may create opportunities for some arbitrage if properly timed.
Using INVO Bioscience hype-based prediction, you can estimate the value of INVO Bioscience from the perspective of INVO Bioscience response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in INVO Bioscience to buy its stock at a price that has no basis in reality. In that case, they are not buying INVO because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

INVO Bioscience after-hype prediction price

    
  USD 1.22  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of INVO Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.040.8013.98
Details
Naive
Forecast
LowNextHigh
0.020.8914.07
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.820.850.88
Details

INVO Bioscience After-Hype Price Prediction Density Analysis

As far as predicting the price of INVO Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in INVO Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of INVO Bioscience, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

INVO Bioscience Estimiated After-Hype Price Volatility

In the context of predicting INVO Bioscience's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on INVO Bioscience's historical news coverage. INVO Bioscience's after-hype downside and upside margins for the prediction period are 0.06 and 14.40, respectively. We have considered INVO Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.84
1.22
After-hype Price
14.40
Upside
INVO Bioscience is out of control at this time. Analysis and calculation of next after-hype price of INVO Bioscience is based on 3 months time horizon.

INVO Bioscience Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as INVO Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading INVO Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with INVO Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.74 
13.18
  0.42 
  0.02 
3 Events / Month
3 Events / Month
In about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.84
1.21
43.57 
2,312  
Notes

INVO Bioscience Hype Timeline

INVO Bioscience is currently traded for 0.84. The entity has historical hype elasticity of 0.42, and average elasticity to hype of competition of -0.02. INVO is anticipated to increase in value after the next headline, with the price projected to jump to 1.206 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 43.57%, whereas the daily expected return is currently at 0.74%. The volatility of related hype on INVO Bioscience is about 47071.43%, with the expected price after the next announcement by competition of 0.82. INVO Bioscience currently holds 8.68 M in liabilities with Debt to Equity (D/E) ratio of 0.6, which is about average as compared to similar companies. INVO Bioscience has a current ratio of 1.95, which is within standard range for the sector. Note, when we think about INVO Bioscience's use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next anticipated press release will be in about 3 days.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

INVO Bioscience Related Hype Analysis

Having access to credible news sources related to INVO Bioscience's direct competition is more important than ever and may enhance your ability to predict INVO Bioscience's future price movements. Getting to know how INVO Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how INVO Bioscience may potentially react to the hype associated with one of its peers.

INVO Bioscience Additional Predictive Modules

Most predictive techniques to examine INVO price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for INVO using various technical indicators. When you analyze INVO charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About INVO Bioscience Predictive Indicators

The successful prediction of INVO Bioscience stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as INVO Bioscience, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of INVO Bioscience based on analysis of INVO Bioscience hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to INVO Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to INVO Bioscience's related companies.

Story Coverage note for INVO Bioscience

The number of cover stories for INVO Bioscience depends on current market conditions and INVO Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that INVO Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about INVO Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

INVO Bioscience Short Properties

INVO Bioscience's future price predictability will typically decrease when INVO Bioscience's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of INVO Bioscience often depends not only on the future outlook of the potential INVO Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. INVO Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.6 M
Cash And Short Term Investments232.4 K
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Consideration for investing in INVO Stock

If you are still planning to invest in INVO Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the INVO Bioscience's history and understand the potential risks before investing.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios